Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amicus Therapeutics (FOLD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,838,867
  • Shares Outstanding, K 223,709
  • Annual Sales, $ 91,250 K
  • Annual Income, $ -349,000 K
  • 60-Month Beta 1.85
  • Price/Sales 31.55
  • Price/Cash Flow N/A
  • Price/Book 7.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.30
  • Number of Estimates 6
  • High Estimate -0.23
  • Low Estimate -0.39
  • Prior Year -0.28
  • Growth Rate Est. (year over year) -7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.39 +2.42%
on 04/18/19
14.61 -13.17%
on 04/08/19
-0.84 (-6.21%)
since 03/18/19
3-Month
10.30 +23.20%
on 01/24/19
14.61 -13.17%
on 04/08/19
+0.38 (+3.09%)
since 01/18/19
52-Week
8.27 +53.45%
on 12/24/18
17.62 -27.98%
on 06/20/18
-2.08 (-14.08%)
since 04/18/18

Most Recent Stories

More News
Amicus Therapeut Falls 3.28% on Heavy Volume: Watch For Potential Rebound

Amicus Therapeut (NASDAQ:FOLD) traded in a range yesterday that spanned from a low of $13.32 to a high of $13.82. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of...

FOLD : 12.69 (-1.40%)
Amicus Therapeutics to Present Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting

Amicus Therapeutics (Nasdaq: FOLD) today announced the company will present initial preclinical data from its investigational adeno-associated viral (AAV) gene therapy program for Pompe disease in a poster...

FOLD : 12.69 (-1.40%)
Amicus Therapeut Shares Up 6.2% Since SmarTrend's Buy Recommendation (FOLD)

SmarTrend identified an Uptrend for Amicus Therapeut (NASDAQ:FOLD) on March 1st, 2019 at $13.13. In approximately 1 month, Amicus Therapeut has returned 6.17% as of today's recent price of $13.94.

FOLD : 12.69 (-1.40%)
Amicus Therapeutics (FOLD) Up 12.4% Since Last Earnings Report: Can It Continue?

Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

FOLD : 12.69 (-1.40%)
Detailed Research: Economic Perspectives on Five Below, INVESCO MORTGAGE CAPITAL INC, Amicus Therapeutics, Akamai Technologies, Kura Oncology, and Columbus McKinnon -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Five Below, Inc. (NASDAQ:FIVE),...

FOLD : 12.69 (-1.40%)
FIVE : 141.65 (+1.37%)
IVR : 16.13 (+0.06%)
AKAM : 75.34 (-0.91%)
CMCO : 40.07 (-0.47%)
KURA : 14.91 (+1.22%)
Amicus Therapeutics Issued Two U.S. Patents for Pompe Enzyme ATB200

Amicus Therapeutics (Nasdaq: FOLD) today announced that the United States Patent and Trademark Office has issued two new patents directed to the composition of matter and methods of making ATB200, a unique...

FOLD : 12.69 (-1.40%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (FOLD , PTLA , SGMO , ICPT , FLXN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

FOLD : 12.69 (-1.40%)
SGMO : 11.70 (unch)
PTLA : 33.70 (+2.06%)
Amicus (FOLD) Reports Wider-than-Expected-Loss for 2018

Amicus (FOLD) reports wider-than-expected loss in 2018, while revenues exceed estimates.

FOLD : 12.69 (-1.40%)
CELG : 93.76 (-0.57%)
BGNE : 119.80 (-1.02%)
BDSI : 4.65 (-0.64%)
April 12th Options Now Available For Amicus Therapeutics (FOLD)

Investors in Amicus Therapeutics Inc saw new options become available today, for the April 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the FOLD options chain...

FOLD : 12.69 (-1.40%)
Amicus Therapeutics Announces Full-Year 2018 Financial Results and 2019 Corporate Updates

Continued Strong Galafold Launch Trends in Early 2019 - On Track to Achieve FY19 Revenue Guidance of $160M-$180M

FOLD : 12.69 (-1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade FOLD with:

Business Summary

AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in...

See More

Key Turning Points

2nd Resistance Point 13.43
1st Resistance Point 13.06
Last Price 12.69
1st Support Level 12.35
2nd Support Level 12.02

See More

52-Week High 17.62
Fibonacci 61.8% 14.05
Fibonacci 50% 12.95
Last Price 12.69
Fibonacci 38.2% 11.84
52-Week Low 8.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar